Disease outcome of inflammatory bowel disease patients: General outline of a Europe-wide population-based 10-year clinical follow-up study

References

• Stockbrugger R, Russel MGVM, Shivananda S. EC-IBD: a European effort in inflammatory bowel disease. Eur J Internal Med 2000; 11: 187–90
   PubMedGoogle Scholar
• Shivananda S, Lennard Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690–7
   PubMed Web of Science ®Google Scholar
• Lennard Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 1997; 9: 353–9
   PubMed Web of Science ®Google Scholar
• Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000; 35: 1272–7
   PubMed Web of Science ®Google Scholar
• Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001; 36: 1307–13
   PubMed Web of Science ®Google Scholar
• Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998; 4: 182–6
   PubMed Web of Science ®Google Scholar
• Eijk IVD. Quality of care and quality of life in inflammatory bowel disease. Maastricht: University of Maastricht. ISBN 5278 336 2002; 90: 5
   Google Scholar
• European Commission, fifth framework shared cost action (QLG4-CT-2000-01414). 2001-2005.
   Google Scholar
• Lennard Jones, JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170:2–6; discussion 16–9.
   Web of Science ®Google Scholar
• Wolters, FL, Zeijl, GV, Wessels, F, Limonard, C, Russel, MGVM, Stockbrügger, RW. Internet-based data inclusion in a European epidemiological follow-up study of IBD patients: a description of methods used. World J Gastroenterol 2005 Dec 7;11(45):7152–8.
   PubMed Web of Science ®Google Scholar
• Wolters, FL, Zeijl, GV, Wessels, F, Limonard, C, Russel, MGVM, Stockbrügger, RW. Internet-based data inclusion in a European epidemiological follow-up study of IBD patients: a description of methods used and analysis of factors influencing response rates. In: Digestive Disease Eeek; 2005. Chicago, USA: 2005.
   Google Scholar
• Riis, L, Wolters, FL, Solberg, C, Veiera, A, Pierik, M, Boutron, M, , et al. Regional differences in prevalence of single nucleotide polymorphisms in CARD15/NOD2 but not in toll-like receptor 4 (TLR4) ASp299Gly polymorphism in patients with inflammatory bowel disease (IBD) across Europe: results from the EC-IBD study group. In: United European Gastroenterology Week; 2004; PragueCzech Republic.
   Google Scholar
• Riis, L, Wolters, FL, Solberg, C, Vermeire, S, Odes, S, Beltrami, M, , et al. Asca is associated with Card15 mutations and longitudinal changes in behaviour of Crohn's disease. In: Digestive Disease Week; 2005. ChicagoUSA: 2005.
   Google Scholar
• Wolters, FL, Schouten, LJ, Sijbrandij, J, Moum, B, Russel, MG, Stockbrugger, R. Increased mortality ten years after diagnosis in a Europe-wide population-based cohort of Crohn's disease patients (EC-IBD Study Group). In: Digestive Disease Week; 2005. ChicagoUSA: 2005.
   Google Scholar
• Wolters, FL, Sijbrandij, J, Ambergen, T, Moum, B, Russel, MG, Stockbrugger, R. Phenotype at diagnosis predetermines disease recurrence pattern: a population-based European Crohn's disease inception cohort (EC-IBD Study Group). In: Digestive Disease Week; 2005. ChicagoUSA: 2005.
   Google Scholar
• Hoie, O, Wolters, FL, Riis, L, Butron, M, Katsanos, K, Mouzas, I, , et al. Colectomy rates in ulcerative colitis in a European inception cohort followed for ten years by the EC-IBD Study Group. In: Digestive Disease Week; 2005. ChicagoUSA: 2005.
   Google Scholar
• Odes, S, Vardi, H, Riis, L, Moum, B, Politi, P, Tsianos, EV, , et al. Cost-analysis and cost determinants in inflammatory bowel disease. The European Collaborative Study Group on Inflammtrory Bowel Disease (EC-IBD) inception cohort with 10 years’ follow-up. In: Digestive Disease Week; 2005. ChicagoUSA: 2005.
   Google Scholar
• Bodini, P, Politi, P, Mortilla, D, Formisano, D, Fornaciari, G, Stockbrugger, R. Communication for IBD patients: present status and future perspectives. In: Digestive Disease Week; 2005. ChicagoUSA: 2005.
   Google Scholar
• Molinie F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France. Gut ;53 1988; 2004: 843–8
   Google Scholar
• Hildebrand H, Finkel Y, Grahnquist L, Lindholm J, Ekbom A, Askling J. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm –2001. Gut ;52 1990; 2003: 1432–4
   Google Scholar
• Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades?. Aliment Pharmacol Ther 2004; 20: 483–96
   PubMed Web of Science ®Google Scholar
• Longobardi T, Jacobs P, Bernstein CN. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis. Am J Gastroenterol 2004; 99: 650–5
   PubMed Web of Science ®Google Scholar
• Metge CJ, Blanchard JF, Peterson S, Bernstein CN. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001; 96: 3348–55
   PubMed Web of Science ®Google Scholar
• Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999; 117: 49–57
   PubMed Web of Science ®Google Scholar